DDX39A Polyclonal Antibody

Catalog number E-AB-18651-01

Choose a variant (4 options)

Selecting a variant updates its price, size and availability.

Price for E-AB-18651-01

Size / count 20 µL

Specifications

Catalog number: E-AB-18651-01
Size / count: 20 µL
Dry ice: No
Hazardous: No
Discontinued: No
Background: This gene encodes a member of the DEAD box protein family. These proteins are characterized by the conserved motif Asp-Glu-Ala-Asp (DEAD) and are putative RNA helicases. They are implicated in a number of cellular processes involving alteration of RNA secondary structure, such as translation initiation, nuclear and mitochondrial splicing, and ribosome and spliceosome assembly. Based on their distribution patterns, some members of the DEAD box protein family are believed to be involved in embryogenesis, spermatogenesis, and cellular growth and division. This gene is thought to play a role in the prognosis of patients with gastrointestinal stromal tumors. A pseudogene of this gene is present on chromosome 13. Alternate splicing results in multiple transcript variants. Additional alternatively spliced transcript variants of this gene have been described, but their full-length nature is not known.
Abbreviation: DDX39A
UniProt: O00148
Host: Rabbit
Reactivity: Human; Mouse; Rat
Immunogen: Fusion protein of human DDX39A
Target: ATP dependent RNA helicase DDX39; ATP-dependent RNA helicase DDX39A; BAT1; BAT1L; DDX39; DDXL; DEAD (Asp-Glu-Ala-Asp) box polypeptide 39 isoform 2; DEAD (Asp-Glu-Ala-Asp) box polypeptide 39A; DEAD box protein 39; DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 39; Eukaryotic initiation factor 4a; Nuclear RNA helicase URH49; Nuclear RNA helicase; DECD variant of DEAD box family; UAP56 related helicase; UAP56 related helicase; 49 kDa; URH49; wu:fc87b12; zgc:55881
Clonality: Polyclonal
Conjugation: Unconjugated
Applications: IHC
Field of Research: Cancer; Epigenetics and Nuclear Signaling
Purification: Antigen affinity purification
Concentration: 0.96 mg/mL
Dilution: IHC 1:50-1:200
Buffer: PBS with 0.05% NaN3 and 40% Glycerol, pH7.4
Shipping Conditions: The product is shipped with ice pack, upon receipt, store it immediately at the temperature recommended.
Storage Conditions: Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.
Isotype: IgG

Frequently Asked Questions

What is the catalog number for DDX39A Polyclonal Antibody?

The catalog number for DDX39A Polyclonal Antibody is E-AB-18651.

What sizes are available for DDX39A Polyclonal Antibody?

DDX39A Polyclonal Antibody is available in the following size(s): 20 µL, 60 µL, 120 µL, 200 µL.

How many pack sizes does DDX39A Polyclonal Antibody come in?

DDX39A Polyclonal Antibody is available in 4 different pack sizes.

Is DDX39A Polyclonal Antibody in stock?

DDX39A Polyclonal Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

Who manufactures DDX39A Polyclonal Antibody?

DDX39A Polyclonal Antibody is manufactured by Elabscience.

What is the estimated delivery time for DDX39A Polyclonal Antibody?

Estimated delivery time for DDX39A Polyclonal Antibody is approximately 15 business day(s), depending on your location.

Where can I find the safety data sheet (SDS/MSDS) for DDX39A Polyclonal Antibody?

The safety data sheet for DDX39A Polyclonal Antibody is available here: https://789.bio/eb/HafvzP.

Is this kit compatible with automated liquid handling platforms?

Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.

What applications has this product been validated for?

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

How do I reconstitute this lyophilized product?

Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.